MedTrace Logo

Weight, Energy, Lipids, and the Liver (WELL) Study

NCT05199948 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2026-04-21

No results posted yet for this study

Summary

The research study is a parallel arm, randomized placebo-controlled clinical trial designed to assess changes in hepatic lipid accumulation, visceral adipose tissue and postprandial lipid, markers of inflammation and energy metabolism in participants who consume 3 study foods per day for 16 week, while maintaining their body weight.

Conditions

  • Nonalcoholic Fatty Liver

Interventions

OTHER

Soybean Oil Foods

Three food product containing 10g of soybean oil each will be consumed each day for a today of 30g of soybean oil consumed each day

OTHER

Palm Oil Foods

Three food product containing 10g of palm oil each will be consumed each day for a today of 30g of palm oil consumed each day

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-02
Primary Completion
2025-09-01
Completion
2026-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05199948 on ClinicalTrials.gov